Itranox 200 Capsule contains Itraconazole 200mg, a broad-spectrum triazole antifungal agent indicated for the treatment of various fungal infections. Itraconazole exerts its antifungal activity by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is effective against a wide range of dermatophytes, yeasts, and molds, including Candida species, Aspergillus species, and dermatophytic fungi responsible for onychomycosis, blastomycosis, histoplasmosis, and other systemic and superficial mycoses. Itranox 200 Capsule is typically administered orally and is well-absorbed in the gastrointestinal tract, with enhanced bioavailability when taken with food. The dosing regimen varies depending on the type and severity of infection, and treatment duration may extend from several weeks to months to ensure complete eradication of the pathogen. Common adverse effects include gastrointestinal disturbances, headache, and rash, while serious side effects such as hepatotoxicity and cardiac issues are rare but warrant monitoring. Itranox 200 Capsule should be used cautiously in patients with liver impairment and contraindicated with certain drugs due to potential interactions. It is essential to follow prescribed dosage and consult a healthcare professional before use.